Form 8-K - Current report:
SEC Accession No. 0001437749-17-018906
Filing Date
2017-11-09
Accepted
2017-11-09 16:21:16
Documents
19
Period of Report
2017-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20171030_8k.htm 8-K 25221
2 EXHIBIT 99.1 ex_98103.htm EX-99.1 146427
3 EXHIBIT 99.2 ex_98104.htm EX-99.2 8532
4 slide14.jpg GRAPHIC 70785
5 slide13.jpg GRAPHIC 95833
6 slide12.jpg GRAPHIC 184612
7 slide11.jpg GRAPHIC 330596
8 slide10.jpg GRAPHIC 272547
9 slide09.jpg GRAPHIC 349159
10 slide08.jpg GRAPHIC 312092
11 slide07.jpg GRAPHIC 333082
12 slide06.jpg GRAPHIC 307952
13 slide05.jpg GRAPHIC 251646
14 slide04.jpg GRAPHIC 267320
15 slide03.jpg GRAPHIC 116986
16 slide02.jpg GRAPHIC 466894
17 slide01.jpg GRAPHIC 95833
18 ex99-1img002.jpg GRAPHIC 3740
19 ex99-1img001.jpg GRAPHIC 2054
  Complete submission text file 0001437749-17-018906.txt   4935929
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 171191136
SIC: 2834 Pharmaceutical Preparations